Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Cyd Nourigat McKay"'
Autor:
Quy Le, Thao Tang, Amanda Leonti, Sommer Castro, Cyd Nourigat McKay, LaKeisha Perkins, Laura Pardo, Danielle Kirkey, Tiffany Hylkema, Lindsey Call, Makia Manselle, Cristina Abrahams, Kristin Bedard, Arturo Molina, Lisa Eidenshinck Brodersen, Michael R. Loken, Katherine Tarlock, Soheil Meshinchi, Keith R. Loeb
Publikováno v:
Blood Advances. 7:1666-1670
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfe9eaad79fc783e4ad266909765d472
https://doi.org/10.1182/bloodadvances.2022008303
https://doi.org/10.1182/bloodadvances.2022008303
Autor:
Danielle C. Kirkey, Anisha M. Loeb, Sommer Castro, Cyd Nourigat McKay, LaKeisha Perkins, Laura Pardo, Amanda R. Leonti, Thao T. Tang, Michael R. Loken, Lisa Eidenschink Brodersen, Keith R. Loeb, David A. Scheinberg, Quy Le, Soheil Meshinchi
Publikováno v:
Blood Advances. 7:1178-1189
Preferentially Expressed Antigen in Melanoma (PRAME), a cancer-testis antigen, provides an ideal target for immunotherapy in acute myeloid leukemia (AML). We have shown expression of PRAME in a significant subset of childhood and adult AML and lack o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9d77d911a8410e62c1149667c59de5c
https://doi.org/10.1182/bloodadvances.2022008304
https://doi.org/10.1182/bloodadvances.2022008304
Targeting FOLR1 in high-risk CBF2AT3-GLIS2 pediatric AML with STRO-002 FOLR1–antibody-drug conjugate
Autor:
Thao Tang, Quy Le, Sommer Castro, Laura Pardo, Cyd Nourigat McKay, LaKeisha Perkins, Jenny Smith, Danielle Kirkey, Cristina Abrahams, Kristin Bedard, Arturo Molina, Lisa Eidenshinck Brodersen, Michael R. Loken, Katherine Tarlock, Soheil Meshinchi, Keith R. Loeb
Publikováno v:
Blood Advances. 6:5933-5937
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd196a3a583adb7ed27c325e380b574b
https://doi.org/10.1182/bloodadvances.2022008503
https://doi.org/10.1182/bloodadvances.2022008503
Therapeutic Targeting of Mesothelin with Chimeric Antigen Receptor T Cells in Acute Myeloid Leukemia
Autor:
Katherine Tarlock, Salvatore Fiorenza, Soheil Meshinchi, Lindsey F Call, Quy Le, Cameron J. Turtle, Anisha M Loeb, Cyd Nourigat McKay, Jenny L. Smith, Michael R. Loken, Shivani Srivastava, LaKeisha Perkins, Rhonda E. Ries, Stanley R. Riddell, Amanda R. Leonti, Colin Correnti, Laura Pardo, Thao T. Tang, Tiffany A. Hylkema, Sommer Castro
Publikováno v:
Clinical Cancer Research. 27:5718-5730
Purpose: We previously identified mesothelin (MSLN) as highly expressed in a significant fraction of acute myeloid leukemia (AML) but entirely silent in normal hematopoiesis, providing a promising antigen for immunotherapeutic targeting that avoids h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f065418da887725fff132a03b0ce968c
https://doi.org/10.1158/1078-0432.ccr-21-1546
https://doi.org/10.1158/1078-0432.ccr-21-1546